Opus Genetics, Inc. Logo

Opus Genetics, Inc.

Clinical-stage company developing gene therapies for inherited retinal diseases.

IRD | US

Overview

Corporate Details

ISIN(s):
US67577R1023 (+2 more)
LEI:
Country:
United States of America
Address:
8 DAVIS DRIVE, 27713 DURHAM

Description

Opus Genetics, Inc. is a clinical-stage ophthalmic biopharmaceutical company that develops gene therapies to treat inherited retinal diseases (IRDs) and other retinal disorders. The company focuses on advancing treatments that address genetic mutations causing vision loss. Its pipeline targets conditions such as Leber congenital amaurosis (LCA), bestrophinopathy (Best disease), and retinitis pigmentosa (RP). The company's primary mission is to restore vision and prevent blindness by creating an efficient path to bring new therapies to the clinic for patients with inherited blinding conditions.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Select rows to enable
Date Filing Language Type / Size Actions
2025-12-19 17:05
8-K
English ZIP 57.5 KB
2025-12-12 02:52 English ZIP 9.3 KB
2025-12-11 23:35
PRIMARY DOCUMENT
English ZIP 8.2 KB
2025-11-12 13:23
10-Q
English ZIP 1.8 MB
2025-11-12 13:07
8-K
English ZIP 100.1 KB
2025-11-06 22:31
8-K
English ZIP 387.7 KB
2025-11-06 14:25
FORM 8-K
English ZIP 101.0 KB
2025-11-06 14:24
FWP
English ZIP 12.0 KB
2025-11-06 14:22
424B5
English ZIP 411.1 KB
2025-11-05 22:06 English ZIP 7.2 KB
2025-11-04 22:22 English ZIP 6.6 KB
2025-10-24 22:16 English ZIP 6.6 KB
2025-09-30 13:24
8-K
English ZIP 8.4 MB
2025-09-26 22:59
S-8
English ZIP 121.3 KB
2025-09-12 00:03 English ZIP 7.4 KB

Automate Your Workflow. Get a real-time feed of all Opus Genetics, Inc. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Opus Genetics, Inc.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Opus Genetics, Inc. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

4BASEBIO PLC Logo
Manufactures GMP-grade synthetic DNA for next-generation therapeutics and vaccines.
United Kingdom
4BB
4D Molecular Therapeutics, Inc. Logo
Develops genetic medicines using AAV vectors for ophthalmology and pulmonology diseases.
United States of America
FDMT
4SC AG Logo
Biopharmaceutical company with no products under development or operational business.
Germany
VSC
60 DEGREES PHARMACEUTICALS, INC. Logo
Develops and commercializes medicines for infectious diseases, focusing on tropical illnesses.
United States of America
SXTP
89bio, Inc. Logo
Clinical-stage biopharma developing therapies for liver and cardiometabolic diseases.
United States of America
ETNB
Aardvark Therapeutics, Inc. Logo
Clinical-stage biopharma developing therapeutics for hunger and metabolic diseases.
United States of America
AARD
ABBOTT LABORATORIES Logo
Global healthcare company in medical devices, diagnostics, nutrition & pharmaceuticals.
United States of America
ABT
AbbVie Inc. Logo
A research-based biopharmaceutical company developing and manufacturing medicines.
United States of America
ABBV
AbCellera Biologics Inc. Logo
Discovers and develops antibody-based therapeutics using a proprietary platform.
United States of America
ABCL
Develops antibody-based therapeutics using CAR-T, NEST, and AffiMab platforms.
South Korea
174900

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.